These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32420743)

  • 21. A Fragment-Based Competitive
    McCarthy WJ; Thomas SE; Olaleye T; Boland JA; Floto RA; Williams G; Blundell TL; Coyne AG; Abell C
    Angew Chem Int Ed Engl; 2024 Sep; 63(37):e202406846. PubMed ID: 38896426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragment-based drug discovery and its application to challenging drug targets.
    Price AJ; Howard S; Cons BD
    Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Novel NMR-Based Protocol to Screen Ultralow Molecular Weight Fragments.
    Favaro A; Sturlese M
    J Med Chem; 2024 Mar; 67(5):3874-3884. PubMed ID: 38426508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency of hit generation and structural characterization in fragment-based ligand discovery.
    Larsson A; Jansson A; Åberg A; Nordlund P
    Curr Opin Chem Biol; 2011 Aug; 15(4):482-8. PubMed ID: 21724447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-based drug design.
    Feyfant E; Cross JB; Paris K; Tsao DH
    Methods Mol Biol; 2011; 685():241-52. PubMed ID: 20981527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unravelling novel congeners from acetyllysine mimicking ligand targeting a lysine acetyltransferase PCAF bromodomain.
    Suryanarayanan V; Singh SK
    J Biomol Struct Dyn; 2018 Dec; 36(16):4303-4319. PubMed ID: 29228881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragments as Novel Starting Points for tRNA-Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies.
    Hassaan E; Eriksson PO; Geschwindner S; Heine A; Klebe G
    ChemMedChem; 2020 Feb; 15(3):324-337. PubMed ID: 31808981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.
    Li Q; Kang C
    Curr Top Med Chem; 2021; 21(13):1099-1112. PubMed ID: 34348623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
    Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
    Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification?
    Wielens J; Headey SJ; Rhodes DI; Mulder RJ; Dolezal O; Deadman JJ; Newman J; Chalmers DK; Parker MW; Peat TS; Scanlon MJ
    J Biomol Screen; 2013 Feb; 18(2):147-59. PubMed ID: 23139382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fragments: where are we now?
    Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
    Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fragment-based drug discovery using rational design.
    Jhoti H
    Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation.
    Wood DJ; Lopez-Fernandez JD; Knight LE; Al-Khawaldeh I; Gai C; Lin S; Martin MP; Miller DC; Cano C; Endicott JA; Hardcastle IR; Noble MEM; Waring MJ
    J Med Chem; 2019 Apr; 62(7):3741-3752. PubMed ID: 30860382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biophysical screening for the discovery of small-molecule ligands.
    Ciulli A
    Methods Mol Biol; 2013; 1008():357-88. PubMed ID: 23729259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design.
    Moore J; Abdul-Manan N; Fejzo J; Jacobs M; Lepre C; Peng J; Xie X
    J Synchrotron Radiat; 2004 Jan; 11(Pt 1):97-100. PubMed ID: 14646145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragment Hits: What do They Look Like and How do They Bind?
    Giordanetto F; Jin C; Willmore L; Feher M; Shaw DE
    J Med Chem; 2019 Apr; 62(7):3381-3394. PubMed ID: 30875465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer.
    Petros AM; Korepanova A; Jakob CG; Qiu W; Panchal SC; Wang J; Dietrich JD; Brewer JT; Pohlki F; Kling A; Wilcox K; Lakics V; Bahnassawy L; Reinhardt P; Partha SK; Bodelle PM; Lake M; Charych EI; Stoll VS; Sun C; Mohler EG
    J Med Chem; 2019 Apr; 62(8):4120-4130. PubMed ID: 30933499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization and Evaluation of Site-Identification by Ligand Competitive Saturation (SILCS) as a Tool for Target-Based Ligand Optimization.
    Ustach VD; Lakkaraju SK; Jo S; Yu W; Jiang W; MacKerell AD
    J Chem Inf Model; 2019 Jun; 59(6):3018-3035. PubMed ID: 31034213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
    Wollenhaupt J; Metz A; Barthel T; Lima GMA; Heine A; Mueller U; Klebe G; Weiss MS
    Structure; 2020 Jun; 28(6):694-706.e5. PubMed ID: 32413289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of pentapeptide-inhibitor hits targeting FKBP51 by combining computational modeling and X-ray crystallography.
    Han JT; Zhu Y; Pan DB; Xue HX; Wang S; Peng Y; Liu H; He YX; Yao X
    Comput Struct Biotechnol J; 2021; 19():4079-4091. PubMed ID: 34401048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.